Status:
UNKNOWN
Effectiveness and Safety of Oil Extracts Medical Cannabis Treatment for Patients With Chronic Pain
Lead Sponsor:
Dorit Pud
Collaborating Sponsors:
Rambam Health Care Campus
Sheba Medical Center
Conditions:
Chronic Pain
Eligibility:
All Genders
18+ years
Brief Summary
Background: The current study will prospectively follow-up on chronic pain patients treated with oil extracts of medical cannabis (MC) for a period of six months in "real life" conditions. This study ...
Detailed Description
The use of medical cannabis (MC) for the treatment of chronic pain has risen in the last decade. According to the Israel Medical Cannabis Unit (IMCU) of the Israeli Ministry of Health (IMOH), there ar...
Eligibility Criteria
Inclusion
- Patients that will be recommended to use oil extracts medical cannabis for the treatment of all forms of chronic pain (despite cancer)
- Patients above the age of 18 years
- Patients who will sign an informed consent after receiving explanation on the requirements, duration and nature of the study
- Only patients who will receive at least one dose of cannabis within the context of the study, will be included in the analysis.
Exclusion
- Patients who lack the ability to understand the purpose and instructions of the study.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04031313
Start Date
August 1 2019
End Date
July 1 2021
Last Update
September 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel